Use of Surgical Quality Metrics Improves Early NSCLC Outcomes
Adhering to surgical quality metrics may improve overall survival and recurrence-free survival for...
Read More
Spotlight
Heart Failure & Iron Deficiency eBook
Focus on Iron Deficience HF 2023v1.indd
Read More
Complete Response to Antihistamines Therapy Tied to Low Disease Activity in CSU
Patients with chronic spontaneous urticaria (CSU) with a urticaria activity score (UAS) of less...
Read More
Geography & Race’s Effect on Chronic Spontaneous Urticaria Management
The following is a summary of “Do regional geography and race influence management of...
Read More
Blastocystis and Chronic Spontaneous Urticaria: Possible microRNA-based Mechanisms
The following is a summary of “Possible microRNA-based mechanism underlying relationship between...
Read More
Patient Voice Is Key Component of CME for Management of CSU
Inclusion of the patient voice into continuing medical education (CME) was linked with effective...
Read More
Sublobar Resection Not Inferior to Lobectomy in Early-Stage NSCLC
In terms of disease-free survival, sublobar resection was not inferior to lobectomy for patients...
Read More
IgE May Predict Response to Omalizumab in Patients With CSU
Baseline levels of IgE may serve as a predictor of response to omalizumab in patients with chronic...
Read More
Clinical Phenotypes Indicate Lack of Therapeutic Response in CSU
In chronic spontaneous urticaria (CSU), the identification of clinical phenotypes enables early...
Read More
The Advantage of Complete Response to Treatment in CSU Patients
The following is a summary of “Benefit of Complete Response to Treatment in Patients With...
Read More
Complete Treatment Response Benefits Patients With CSU
For patients with chronic spontaneous urticaria (CSU), disease management is strongly associated...
Read More
Even With Delay, Surgery Improves Survival in Early NSCLC Versus Stereotactic Radiation
Surgery was superior to stereotactic radiation for early non-small cell lung cancer, even in the...
Read More
Investigational and Existing Medicine for Refractory CSU
The following is the summary of “Existing and Investigational Medications for Refractory Chronic...
Read MoreAnalyzing SEER Medicare Data for eNSCLC Patients
The following is the summary of “Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare Data” published in the December 2022 issue of Lung Cancer by West, et al. As...
Read More
Survival and Treatment Patterns of Early-stage NSCLC Patients with Locoregional Recurrence
The following is the summary of “Treatment patterns and survival of patients with locoregional...
Read More
Wedge Resections & Underutilization of Adv Chemotherapy Linked with Non-examination of LN in eNSCLC
The following is the summary of “946P – Non-examination of lymph nodes (LN) in early-stage...
Read More
Increased SBRT in eNSCLC Reduces Racial Disparities & Mortality
For patients with early-stage non-small cell lung cancer (eNSCLC), increased use of stereotactic...
Read More
Mobile Phone Call Reminders Improve Compliance With Iron Supplementation
In antenatal women with iron deficiency anemia, mobile phone call reminders—along with standard...
Read More
Neglected Comorbidity of Chronic Heart Failure: Iron Deficiency
Iron deficiency is a significant comorbidity of heart failure (HF), defined as the inability of...
Read More
Incidence, Treatment and Clinical Impact of Iron Deficiency in Chronic Heart Failure: A Longitudinal Analysis
In patients with heart failure (HF), iron deficiency (ID) is a well-recognized therapeutic target;...
Read More